ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.645,49
0,25%
Dow Jones
40.795,25
1,45%
Euro vs US Dollar
1,08853
-0,13%
Bitcoin
64.498,85
-0,54%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) News

AZN

AstraZeneca (AZN)

AstraZeneca PLC
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AZN
DatumZeitQuelleÜberschriftSymbolFirma
20/08/202112h32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
20/08/202112h20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
20/08/202108h46Dow Jones NewsAstraZeneca: Alexion to Discontinue Ultomiris Phase 3 ALS TrialNASDAQ:AZNAstraZeneca PLC
20/08/202108h46Dow Jones NewsAstraZeneca Says AZD7442 Antibody Phase 3 Trial Met Primary Endpoint in Preventing Covid-19NASDAQ:AZNAstraZeneca PLC
19/08/202115h19Dow Jones NewsMedian FTSE 100 CEO Pay Fell 17% in 2020 to GBP2.7 Million, Report SaysNASDAQ:AZNAstraZeneca PLC
11/08/202116h50Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
11/08/202116h15Dow Jones NewsAstraZeneca Says US FDA Calls for Extra Clinical Trial on Safety of RoxadustatNASDAQ:AZNAstraZeneca PLC
11/08/202113h54Dow Jones NewsFDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney DiseaseNASDAQ:AZNAstraZeneca PLC
09/08/202113h42Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
09/08/202113h32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
09/08/202108h58Dow Jones NewsAstraZeneca's Forxiga Gets EU Approval For Chronic Kidney Disease TreatmentNASDAQ:AZNAstraZeneca PLC
09/08/202108h43Dow Jones NewsAstraZeneca Says Enhertu Improved Survival in Trial Breast-Cancer PatientsNASDAQ:AZNAstraZeneca PLC
03/08/202114h45InvestorWireCardiovascular Disease Drug Market Offers Compelling Potential for First Movers, Innovators in the SpaceNASDAQ:AZNAstraZeneca PLC
02/08/202116h41Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
02/08/202112h23Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
02/08/202108h35Dow Jones NewsAstraZeneca's Saphnelo Approved in U.S. for Moderate-to-Severe SLENASDAQ:AZNAstraZeneca PLC
30/07/202113h40Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:AZNAstraZeneca PLC
29/07/202110h20Dow Jones NewsAstraZeneca Lifts 2021 Guidance After Alexion Acquisition; Posts Lower 2Q Profit -- UpdateNASDAQ:AZNAstraZeneca PLC
29/07/202109h05Dow Jones NewsAstraZeneca 2Q Net Profit Dropped Despite Higher Revenue; Raises GuidanceNASDAQ:AZNAstraZeneca PLC
26/07/202108h37Dow Jones NewsAstraZeneca Gets EU Marketing Authorization RecommendationNASDAQ:AZNAstraZeneca PLC
23/07/202114h29Dow Jones NewsAstraZeneca's Bydureon BCise Gets U.S. Approval For Type 2 Diabetes in Pediatric PatientsNASDAQ:AZNAstraZeneca PLC
23/07/202110h43Dow Jones NewsAstraZeneca's Covid-19 Vaccine Effective Against Variants After One Dose, Canadian Study ShowsNASDAQ:AZNAstraZeneca PLC
22/07/202114h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
21/07/202122h16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
21/07/202118h09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
21/07/202115h53Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
19/07/202115h28Dow Jones NewsAridis to License Suvratoxumab From AstraZenecaNASDAQ:AZNAstraZeneca PLC
19/07/202114h30PR Newswire (US)Aridis Pharmaceuticals Announces Exclusive License of Suvratoxumab, a Phase 3-Ready Monoclonal Antibody, from AstraZenecaNASDAQ:AZNAstraZeneca PLC
19/07/202108h44Dow Jones NewsAstraZeneca Small-Cell Lung Cancer Treatment Imfinzi Approved in ChinaNASDAQ:AZNAstraZeneca PLC
16/07/202112h13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:AZNAstraZeneca PLC
 Showing the most relevant articles for your search:NASDAQ:AZN

Kürzlich von Ihnen besucht

BIT
UB6ZCT
Unicredit Bank
BIT
UC5T03
Unicredit Bank
BIT
P1HLJ4
BNP Paribas Issuance
COIN
FETUSD
Fetch
LSE
VFEM
Vanguard Ftseem
LSE
3LOI
Wt Wticruoil3x
LSE
0MWL
Vaneck Vectors Ucits Etfs
NASDAQ
CENT
Central Garden and Pet
NASDAQ
OSUR
OraSure Technologies
LSE
JET2
Jet2
LSE
0O7H
Ampli Sa W Upadlosci Ukl...
BOV
EZTCG131
EZTCG131 Ex:13,1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten